FDA’s September 2022 NPRMs: What They Mean for Academia and Industry
On September 28, 2022, the Food and Drug Administration (FDA) released two Notices of Proposed Rulemaking (NPRM). These notices proposed
On September 28, 2022, the Food and Drug Administration (FDA) released two Notices of Proposed Rulemaking (NPRM). These notices proposed
In the blink of an eye, the world has gone digital. So many tasks which used to require going to
Crafting informed consent forms requires balancing regulatory compliance with participant understanding, ensuring consent is both meaningful and legally sound.
The Food and Drug Administration (FDA) is the federal entity in the U.S. charged with (among other things) “ensur[ing] that
Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe for transport from a drug
Learn how Endpoint Adjudication Committees ensure safe study conduct, mitigate participant risks, and provide unbiased medical event reviews.
Discover survey findings on trial selection, from cumbersome feasibility questionnaires to improving transparency and site opportunities.
Institutional biosafety committees (IBCs) frequently receive questions about the proper type of hood for use with biological materials and the
Cannabis use has become widespread. As such, we are seeing an uptick in research examining the therapeutic effects of cannabis
Short form consents provide a crucial bridge for unexpected non-English speaking participants, ensuring informed consent remains accessible when translations aren’t readily available.
Efficient document systems like eTMF and eISF enhance compliance and streamline document management, helping sites and sponsors ensure secure, organized trial records.
Recruiting study participants is one of the most challenging tasks in the clinical trial process, and arguably one of the